Stella Pharma Corp. engages in the development, manufacture, and sale of pharmaceuticals. It provides boron-based drugs used for Boron Neutron Capture Therapy (BNCT), a form of radiotherapy that targets cancer cells using biochemical methods. The company was founded on June 1, 2007 and is headquartered in Osaka, Japan.